INmune Bio INMB 深 沪
等待开盘 10-31 09:30:00 美东时间
1.45
-0.150
-9.37%
华盛通- 最 高1.555
- 今 开1.53
- 成交量 18.41万股
- 最 低 1.43
- 昨 收 1.60
- 总市值 4024.30万
- 52周最高 2.60
- 市盈率 静 --
- 换手率 0.66%
- 52周最低 1.09
- 委 比 -54.32%
- 总股本 2775.38万
- 历史最高 30.37
- 量 比 0.92
- 振 幅 7.81%
- 历史最低 1.09
- 每 手 1
- 风险率 0.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Inmune Bio Announces New Equity Financing Agreement
Inmune Bio ( ($INMB) ) has shared an announcement. On October 27, 2026, INmune ...
10-29 19:57
INmune Bio Inc.收涨0.66%，成交额28.28万美元
10月29日，INmune Bio Inc.（INMB）收涨0.66%，报1.53美元，成交额28.28万美元，市值4246.33万美元。 行情数据 • 开盘价...
10-29 07:25
INmune Bio, Inc. Announces Pricing of $4.50 Million Registered Direct Offering and Concurrent Private Placement
INmune Bio Inc. has completed a registered direct offering of 3,000,000 common shares and warrants to purchase an additional 3,000,000 shares, raising approximately $4.5 million. The warrants have an exercise price of $1.65, are exercisable six months after issuance, and expire in 5.5 years. Proceeds will be used for working capital and general corporate purposes. The offering is underwritten by A.G.P./Alliance Global Partners and registered with...
10-28 12:00
INmune Bio Inc.收跌2.05%，成交额23.54万美元
10月27日，INmune Bio Inc.（INMB）收跌2.05%，报1.43美元，成交额23.54万美元，市值3968.79万美元。 行情数据 • 开盘价...
10-27 07:31
INmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-2027
Boca Raton, Florida, October 21st, 2026, FinanceWire Final pre-MAA package subm...
10-21 21:50
INmune Bio advances Ebstrocel toward international commercialization
The latest update is out from Inmune Bio ( ($INMB) ). On October 21, 2026, INmu...
10-21 21:29
INmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-2027
INmune Bio submitted its final pre-MAA package for Ebstrocel™ to the UK MHRA on October 20, 2026, aiming for a full MAA submission in early February 2027, potentially accelerating UK approval by six weeks. The U.S. BLA is expected in Q2 2027. The company updated its strategy due to faster manufacturing progress, replacing a sequential rolling submission. Regulatory advisors and CMC advancements support this timeline. The MHRA response is anticipa...
10-21 11:15
INmune Bio Inc.收跌4.85%，成交额31.27万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:32
INmune Bio And Quantum Computing Inc. Partner To Use Quantum AI To Identify New Treatment Applications For Alzheimer’s Drug XPro
Collaboration combines INmune Bio's clinical research with QCi's Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XPro Initial engagement marks QCi's first commercial customer in pharmaceutical and biotechnology markets, expanding the applicat...
10-14 20:35
Full Transcript: INmune Bio Q2 2026 Earnings Call
INmune Bio (NASDAQ:INMB) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. View the webcast at https...
10-12 17:54
